Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma

Mostrar otras versiones (1)

BACKGROUND: In spite of modern therapies for non-small-cell lung cancer (NSCLC), prognosis for many patients is still poor and survival rates are low. Immunotherapy is the possibility to improve the lung immune response surrounding the tumour. However, this approach requires detailed understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreev, Katerina, Denis Iulian Trufa, I, Siegemund, Raphaela, Rieker, Ralf, Hartmann, Arndt, Schmidt, Joachim, Sirbu, Horia, Finotto, Susetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578079/
https://www.ncbi.nlm.nih.gov/pubmed/26348446
http://dx.doi.org/10.1038/bjc.2015.255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578079/
https://www.ncbi.nlm.nih.gov/pubmed/26348446
http://dx.doi.org/10.1038/bjc.2015.255

Ejemplares similares